Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
Open accessThe DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
Abstract
The purpose of this study was to use serial imaging to gain insight into the sequence of pathologic events in Alzheimer's disease, and the clinical features associated with this sequence. We measured change in amyloid deposition over time using serial (11)C Pittsburgh compound B (PIB) positron emission tomography and progression of neurodegeneration using serial structural magnetic resonance imaging. We studied 21 healthy cognitively normal subjects, 32 with amnestic mild cognitive impairment and 8 with Alzheimer's disease. Subjects were drawn from two sources--ongoing longitudinal registries at Mayo Clinic, and the Alzheimer's disease Neuroimaging Initiative (ADNI). All subjects underwent clinical assessments, MRI and PIB studies at two time points, approximately one year apart. PIB retention was quantified in global cortical to cerebellar ratio units and brain atrophy in units of cm(3) by measuring ventricular expansion. The annual change in global PIB retention did not differ by clinical group (P = 0.90), and although small (median 0.042 ratio units/year overall) was greater than zero among all subjects (P < 0.001). Ventricular expansion rates differed by clinical group (P < 0.001) and increased in the following order: cognitively normal (1.3 cm(3)/year) < amnestic mild cognitive impairment (2.5 cm(3)/year) < Alzheimer's disease (7.7 cm(3)/year). Among all subjects there was no correlation between PIB change and concurrent change on CDR-SB (r = -0.01, P = 0.97) but some evidence of a weak correlation with MMSE (r =-0.22, P = 0.09). In contrast, greater rates of ventricular expansion were clearly correlated with worsening concurrent change on CDR-SB (r = 0.42, P < 0.01) and MMSE (r =-0.52, P < 0.01). Our data are consistent with a model of typical late onset Alzheimer's disease that has two main features: (i) dissociation between the rate of amyloid deposition and the rate of neurodegeneration late in life, with amyloid deposition proceeding at a constant slow rate while neurodegeneration accelerates and (ii) clinical symptoms are coupled to neurodegeneration not amyloid deposition. Significant plaque deposition occurs prior to clinical decline. The presence of brain amyloidosis alone is not sufficient to produce cognitive decline, rather, the neurodegenerative component of Alzheimer's disease pathology is the direct substrate of cognitive impairment and the rate of cognitive decline is driven by the rate of neurodegeneration. Neurodegeneration (atrophy on MRI) both precedes and parallels cognitive decline. This model implies a complimentary role for MRI and PIB imaging in Alzheimer's disease, with each reflecting one of the major pathologies, amyloid dysmetabolism and neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Efforts continue to be placed on the early detection of AD as changes in brain chemistry begin to occur 20 years or more prior to the onset of noticeable cognitive symptoms [137,138,139,140].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [137]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although these symptoms are new to the individual affected, the brain changes that cause them are thought to begin 20 years or more before symptoms start.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies of non-demented elderly cohorts overall report approximately 20–40% are PIB-positive [67, 68, 71–78].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319 · cited 1×
“The automated anatomic labelling (AAL) atlas (Tzourio-Mazoyer et al., 2002) was modified in-house to contain the following labelled regions of interest: right and left parietal, temporal, prefrontal, primary sensory -motor, orbito frontal, anterior cingulate, posterior cingulate/ precuneus and occipital.”
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzem, E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0655 · Cited by 8,477
What's wrong with Bonferroni adjustments
Perneger, T. V. (1998) · BMJ · doi:10.1136/bmj.316.7139.1236 · Cited by 5,900
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Self-citation
Cited by
Items 901–1,000 of 1,000
Zhang, J., Hu, Q., Li, F., & Wu, G. (2024) · Research Square · doi:10.21203/rs.3.rs-3921380/v1 · Cited by 3
Lifestyle, genetic risk, plasma pTau217, and incident cognitive impairment in WRAP
Studer, R. L., Cody, K. A., Oomens, J. E., Reyes, R. E. R., Chin, N. A., Mueller, K. D., Hermann, B. P., Wilson, R. E., Langhough, R. E., Jonaitis, E. M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70573 · Cited by 2
Abbate, C., & Gallucci, A. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251374319 · Cited by 2
Bagnati, P., Allegri, R., Demey, I., Bartoli, G., Bérgamo, Y., Campos, J., de Castro, D. M. P., Méndez, P. C., Cristalli, D. O., Fernandez, C., et al. (2026) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v36i170.946 · Cited by 3
Trajectories of late-life depression: insights from molecular imaging
Holmes, S. E., & Smith, G. S. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02340-2 · Cited by 2
Xu, S., Tang, C., Shi, L., Chen, J., Jia, J., & Qi, J. (2026) · Neurocomputing · doi:10.1016/j.neucom.2026.133697 · Cited by 2
Sambuco, N., Scaramuzzi, G. F., Gasparre, D., Cornacchia, E., Bonvino, A., Antonucci, L. A., Pergola, G., & Taurisano, P. (2026) · Cortex · doi:10.1016/j.cortex.2026.03.022 · Cited by 2
What to make of equivocal amyloid imaging results
Burrell, J. R., Foxe, D., Leyton, C. E., Piguet, O., & Hodges, J. R. (2020) · Neurocase · doi:10.1080/13554794.2020.1764056 · Cited by 2
MR Brain Screening using Optimization Techniques - A Survey
Chitradevi, D., & Prabha, S. (2021) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405617666211126154101 · Cited by 3
Delgado, F. R., Rubio, R. D., Barahona‐Hernando, R., & Rodríguez‐Gómez, O. (2015) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2015.01.001 · Cited by 9
Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions
Villemagne, V. L., Doré, V., Burnham, S. C., & Rowe, C. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_10 · Cited by 2
Lhiyani, N., Sanjeev, A., Mor, A., Beiderman, Y., García, J., & Zalevsky, Z. (2023) · Optics Continuum · doi:10.1364/optcon.471544 · Cited by 2
Zhang, Y., Li, B.-L., & Sun, G. (2023) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2023.113875 · Cited by 2
Structural and Functional Magnetic Resonance Imaging
Lockau, H., Jessen, F., Fellgiebel, A., & Drzezga, A. E. (2013) · PET Clinics · doi:10.1016/j.cpet.2013.08.004 · Cited by 2
Diagnosis of Dementia Using Nuclear Medicine Imaging Modalities
Merissa, N., Garrett, M., & Scott, P. J. H. (2011) · InTech eBooks · doi:10.5772/25283 · Cited by 3
Biomarkers in Alzheimer’s Disease—Perspectives for the Future
Cummings, J. L. (2010) · touchREVIEWS in Neurology · doi:10.17925/usn.2010.06.01.23 · Cited by 3
Lucignani, G., & Perneczky, R. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1361-0 · Cited by 2
Beyond the Dawning of the Age of Biomarkers
Blacker, D. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181f52877 · Cited by 2
Schindowski, K., Schindowski, C., & Zimmermann, J. (2014) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s51786 · Cited by 5
Amyloid imaging for Alzheimer's disease
Kerchner, G. A. (2011) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2011.617365 · Cited by 2
Comparing model‐based cerebrovascular physiomarkers with DTI biomarkers in MCI patients
Marmarelis, V. Z., Shin, D. C., Tarumi, T., & Zhang, R. (2019) · Brain and Behavior · doi:10.1002/brb3.1356 · Cited by 2
Maeno, N. (2019) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001042 · Cited by 3
Hu, D., (ADNI), A. A. D. N. I., Liu, C., Xia, K., Abramowitz, A., & Wu, G. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215160 · Cited by 4
Han, S.-H., Noh, D.-H., Jo, E.-J., & Kam, K.-Y. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215075 · Cited by 3
Cunnane, S. C., Courchesne‐Loyer, A., St‐Pierre, V., Vandenberghe, C., Croteau, É., & Castellano, C. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780190497996.003.0015 · Cited by 4
Ni, R. (2015) · Figshare · Cited by 2
Non-invasive molecular imaging and theranostic probes
Mottaghy, F. M. (2017) · Methods · doi:10.1016/j.ymeth.2017.10.001 · Cited by 2
Karbalaei, R., Rezaei–Tavirani, M., Torkzaban, B., & Jamalkandi, S. A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/245571 · Cited by 3
Stefanovski, L., Meier, J. M., Pai, R. K., Triebkorn, P., Lett, T. A. P., Martin, L., Bülau, K., Hofmann‐Apitius, M., Solodkin, A., McIntosh, A. R., et al. (2020) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/4t5qa · Cited by 2
Perani, D. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.8343973.8791070 · Cited by 2
Gazes, Y., Soldan, A., & Stern, Y. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375000-6.00020-3 · Cited by 4
Nelson, R. B. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45019-8 · Cited by 2
Dökdök, M., Gokmen, M. H. A., Karaman, K., Karadeniz, O., Kütükçü, Y., & Göçmen, S. (2022) · Iranian Journal of Radiology · doi:10.5812/iranjradiol.115141 · Cited by 1
Research on clustering algorithm of cognitive rehabilitation based on multi-dimensional objects
Fan, X., Duan, Z., & Liu, G. (2022) · International Conference on Cloud Computing, Internet of Things, and Computer Applications (CICA) · doi:10.1117/12.2642604 · Cited by 1
Peng, J., Tang, Q., Li, Y., Liu, L., Biswal, B. B., & Wang, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-90872-w · Cited by 1
Strużek, K., Karamus, K., Rejmak, R. W., Borowska-Łygan, M., Urban, W., Tomaszewski, J., Gryc, A., Lipiec, J., & Grudzień, M. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.80.60238 · Cited by 1
Mozafar, M., Shahbazi, S., Amirian, M. A., Shekari, K., Sepahvand, N., Esmaeili, M., Amini, A., Shakeri, S., Mirhosseini, H., Mayeli, M., et al. (2025) · Applied Neuropsychology Adult · doi:10.1080/23279095.2025.2546951 · Cited by 1
Differential MRI atrophy profiles and incident dementia: A cross-national comparison
Walters, M. E., Small, B. J., Andel, R., Lerch, O., Horáková, H., Molinari, V., Salemi, J. L., Vyhnálek, M., Nedelská, Z., Hort, J., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251371734 · Cited by 1
Jorge, L., Canário, N., Martins, R., Abrunhosa, A., Santana, I. J., & Castelo-Branco, M. S. (2025) · Neuroimage Reports · doi:10.1016/j.ynirp.2025.100305 · Cited by 2
Zhang, T., Nie, B., Liu, H., Mao, G., OuYang, C., Jiang, X., & Shan, B. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-026-07797-3 · Cited by 1
Monoclonal antibodies and small molecules: on the cutting edge of Alzheimer’s disease therapy
Ouro, A., Ben-Dor, G. A., Debasa‐Mouce, M., Gulkarov, S., Leon, J. D., Castro‐Mosquera, M., Sobrino, T., Bougea, A. M., & Reiss, A. B. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1766762 · Cited by 1
Early disruptions in brain capillary blood flow control in a mouse model of Alzheimer’s disease
Hariharan, A., Vigderman, A. S., Isaacs, D. P., Weir, N., Park, G., Edwards, S., & Longden, T. A. (2026) · The Journal of General Physiology · doi:10.1085/jgp.202614014 · Cited by 1
MRI- and PET-Based Imaging Markers for the Diagnosis of Alzheimer’s Disease
Teipel, S. J., Sperling, R. A., Skudlarski, P., Jack, C. R., Hampel, H. J., Fellgiebel, A., & Herholz, K. (2012) · Advances in biological psychiatry · doi:10.1159/000335393 · Cited by 1
Self-citationQuantitative characterization of brain β-amyloid using a joint PiB/FDG PET image histogram
Camp, J. J., Hanson, D. P., Holmes, D. R., Kemp, B. J., Senjem, M. L., Murray, M. E., Dickson, D. W., Parisi, J. E., Petersen, R. C., Lowe, V. J., et al. (2014) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2042880 · Cited by 1
Self-citationAmyloid Positron Emission Tomography Imaging for the Differential Diagnosis of Alzheimer's Disease
Tateno, A., Sakayori, T., & Okubo, Y. (2014) · Journal of Nippon Medical School · doi:10.1272/jnms.81.2 · Cited by 1
Möglichkeiten moderner Bildgebungstechnologien im Rahmen der Frühdiagnostik von Alzheimererkrankung
Unschuld, P. G. (2015) · Therapeutische Umschau · doi:10.1024/0040-5930/a000674 · Cited by 1
Relationship Between Cholesterol Metabolism, Apoe and Brain Volumes In Alzheimer‘s Disease
Leoni, V., & Caccia, C. (2011) · Future Neurology · doi:10.2217/fnl.11.38 · Cited by 2
Krolak‐Salmon, P., & Vighetto, A. (2012) · Future Neurology · doi:10.2217/fnl.12.39 · Cited by 1
Vlaslaer, A. V., Mortishire‐Smith, R. J., Mackie, C. E., Langlois, X., & Schmidt, M. E. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-10 · Cited by 1
Ashraf, A., Mehta, P. D., & Edison, P. (2012) · Reviews in Clinical Gerontology · doi:10.1017/s0959259812000160 · Cited by 1
Translational Research in Alzheimer’s Disease for Development of Antibody-Based Therapeutics
Yuen, E., Liu, E., & Kinney, G. G. (2012) · Springer eBooks · doi:10.1007/978-1-4419-5955-3_14 · Cited by 1
Advances in Alzheimer’s Disease Management
Gauthier, S. G., & Rosa‐Neto, P. (2012) · doi:10.2217/9781780840840 · Cited by 1
Amyloid Imaging in Dementia and Related Disorders
Camacho, V., & Carrió, I. (2016) · Springer eBooks · doi:10.1007/978-3-319-31614-7_7 · Cited by 1
What is the Role of Positron Emission Tomography in Drug Development?
McCarthy, T. J. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814317740_0004 · Cited by 1
Chee, M. W. L., & Lee, S. M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511783005.004 · Cited by 1
PET in Neurological and Psychiatric Disorders: Technologic Advances and Clinical Applications
Matusch, A., & Kroll, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-40070-9_20 · Cited by 1
Gene Set Analysis of SNP Data from Genome‐wide Association Studies
Liu, S., Zeng, P., & Liu, Z. (2017) · Wiley eBooks · doi:10.1002/9781118782392.ch24 · Cited by 1
Brain Imaging in Type 2 Diabetes
Moran, C., Beare, R. J., Phan, T. G., & Srikanth, V. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00004-4 · Cited by 2
Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00010-7 · Cited by 1
Reduce the Risk of Dementia; Early Diagnosis of Alzheimer’s Disease
Jakhmola, S., & Jha, H. C. (2018) · Advances in intelligent systems and computing · doi:10.1007/978-981-13-0923-6_53 · Cited by 1
Singh, J., Sabbagh, M. N., Nair, A. K., Grundman, M., Kinney, G. G., Yuen, E., & Black, R. S. (2014) · Wiley eBooks · doi:10.1002/9781118730676.ch23 · Cited by 2
Mitochondrial abnormalities in neurological disorders
Ferreira, A. F. F., Singulani, M. P., & de Britto, L. R. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822416-8.00012-9 · Cited by 1
Diagnosi clinicolaboratoristica della malattia di Alzheimer
Lagarde, J., Olivieri, P., Bottlaender, M., & Sarazin, M. (2021) · EMC - Neurologia · doi:10.1016/s1634-7072(21)45320-1 · Cited by 1
Aine, C. J., Adair, J. C., Knoefel, J. E., Sanfratello, L., & Stephen, J. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-00087-5_31 · Cited by 1
Nwoye, E. O., Fidelis, O. P., Umeh, K., Fadipe, B., Umeh, C. S., Akano, T. T., Jesuoluwa, Z., & Woo, W. L. (2021) · International Journal of Automation Artificial Intelligence and Machine Learning · doi:10.61797/ijaaiml.v2i2.103 · Cited by 1
Harnessing EEG Signals to Detect Schizophrenia: A Deep Learning Approach
Upadhyay, S., Kumari, A. C., & Srinivas, K. (2024) · Algorithms for intelligent systems · doi:10.1007/978-981-97-3526-6_16 · Cited by 1
Boer, P. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1595710 · Cited by 1
Functional and Structural MRI in Alzheimer’s Disease: A Multimodal Approach
Grothe, M. J., Bokde, A. L. W., & Teipel, S. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-54542-9_20 · Cited by 1
Die Rolle personalisierter mHealth-Anwendungen zur Risikoreduktion der Alzheimererkrankung
Khayyal, H. A., & Remmers, H. (2020) · Springer eBooks · doi:10.1007/978-3-658-29133-4_9 · Cited by 1
Aine, C. J., Adair, J. C., Knoefel, J. E., Sanfratello, L., & Stephen, J. M. (2019) · Springer eBooks · doi:10.1007/978-3-319-62657-4_31-1 · Cited by 1
Tchistiakova, E. (2016) · TSpace (University of Toronto) · Cited by 1
Evaluation of a cognitive and a morphometric marker for the early detection of Alzheimer's disease
Kälin, A. M. (2015) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-117647 · Cited by 1
Alfakir, R. (2021) · Research Square · doi:10.21203/rs.3.rs-384231/v2 · Cited by 1
Clerx, L. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140516lc · Cited by 1
Immune regulations in a Drosophila model of Alzheimer's disease
Maksoud, É. (2012) · theses.fr (ABES) · doi:10.70675/1c0d2d8cz36d8z4785zbf04z131c36133de9 · Cited by 2
PET and SPECT Studies of Ageing and Cardiovascular Risk Factors for Alzheimer’s Disease
Busatto, G. F., Tamashiro-Duran, J. H., de Toledo, T. C., Ferreira, L. K., Duran, F., & Buchpiguel, C. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_21
Mechanisms of Brain Region-Specific Amyloid-beta Deposition
Bero, A. W. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7cj8bh2
Neuropathology of Dementia in Parkinson's Disease
Dickson, D. W., & Orr, C. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch14 · Cited by 1
Nanotextured Material for Applications in CSF Sample Screening and Characterization
Vattipalli, K., Brandigampala, S. M., McGraw, C. E., Chatterjee, G., Kasturirangan, S., Schulz, P., Sierks, M. R., & Prasad, S. (2012) · MRS Proceedings · doi:10.1557/opl.2012.1200
Pittsburgh compound B as a marker of cognitive decline
Rinne, J. O. (2010) · Future Neurology · doi:10.2217/fnl.10.23
Association of chronic divalproex sodium use and brain atrophy in Alzheimer’s disease
Han, C., Shim, D. S., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.194
Ordering of Alzheimer Disease Biomarkers—Reply
Jack, C. R. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2908
Self-citationMild Cognitive Impairment: Beyond Memory Dysfunction
Tales, A., Bayer, A. J., Krajcik, S., & Jellinger, K. A. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/262305
Diagnosticare la malattia di Alzheimer
Sarazin, M., Hamelin, L., Lamari, F., & Bottlaender, M. (2014) · EMC - Neurologia · doi:10.1016/s1634-7072(14)67223-8
Ginkgo biloba and Cognitive Decline—Reply
Snitz, B. E. (2010) · JAMA · doi:10.1001/jama.2010.435
SPECIFIC AMYLOID-BETA OLIGOMERS IN HUMAN CEREBROSPINAL FLUID
Handoko, M. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Shi, Z., Ying, W., Liu, S., Liu, S., Zhou, Y., Wang, J., Gao, S., & Ji, Y. (2014) · DOAJ (DOAJ: Directory of Open Access Journals)
Medline, A. (2013) · PubMed · Cited by 1
Filippi, M., Agosta, F., & Spinelli, E. G. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3118-7_17
Price, J. C., Lopresti, B. J., & Villemagne, V. L. (2012) · Neuromethods · doi:10.1007/7657_2012_47
Khan, K. (2010) · Repository@Hull (Worktribe) (University of Hull)
Ramanan, V. K. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1951
Apolipoprotein E and Mitochondria-associated Endoplasmic Reticulum Dysfunction
Tambini, M. D. (2016)
Regulation of apolipoprotein E secretion, lipidation and recycling in the central nervous system
Fan, J. (2014) · cIRcle (University of British Columbia) · doi:10.14288/1.0166830
Molecular Imaging in Alzheimer Clinical Trials
Schmidt, M. E., Matthews, D. C., & Staelens, S. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00020-4
Evaluation and management of dementia
Collins, L., Rovner, B. W., & Collins-Fletcher, K. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107294967.010
Metadata
- Authors
- Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., Weiner, M., & Petersen, R. C.
- Affiliations
- Mayo Clinic (US)
- San Francisco VA Medical Center (US)
- Corresponding author
- Jack, Clifford R.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03-31
- Volume
- 132
- Issue
- 5
- Pages
- 1355-1365
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC2677798
- OpenAlex
- W2133719476
- Cited by
- 1,099
- References
- 83
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 34 · 2023: 51 · 2022: 45 · 2021: 49 · 2020: 60 · 2019: 54 · 2018: 62 · 2017: 46 · 2016: 56 · 2015: 69 · 2014: 73 · 2013: 94 · 2012: 116
- FWCI
- 71.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Brain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Mayo Foundation for Medical Education and Research (AG16574)
- National Institute for Health and Care Research (NF-SI-0508-10123)
- National Institute on Aging (R01AG11378, P01AG010491, P50‐AG16574, U01AG06786, AG 024904, R01AG027342, U01AG006786, R01AG011378, P30AG019610, U19AG010483, P50AG016574)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, mild cognitive impairment, amyloid deposition, neurodegeneration, brain atrophy, ventriculomegaly, Pittsburgh compound B PET, serial imaging, amyloid plaques, cognitive decline, Alzheimer's Disease Neuroimaging Initiative, brain atrophy rate
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Aniline Compounds, Atrophy, Brain, Carbon Radioisotopes, Cognition Disorders, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Thiazoles, Time Factors, Case-Control Studies, Amyloid beta-Peptides, Statistics, Nonparametric, Radiopharmaceuticals, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.